在急性冠状动脉综合征与心脏性休克中短期皮肤通道机械循环支持:选择哪种设备?
Nardi Tetaj1,2, Annunziata Nusca1,2, Francesco Piccirillo1,2
1Cardiology Unit, Campus Bio-Medico University Hospital, Via Alvaro del Portillo 200, 00128 Rome, Italy.
Journal of cardiovascular development and disease
|February 26, 2026
概括
心脏性休克 (CS) 治疗仍然具有挑战性. 像Impella和VA-ECMO这样的皮机械循环支持 (MCS) 设备显示出有希望,但缺乏一致的生存益处,需要个性化策略.
科学领域:
- 心脏病学 心脏病学
- 临界护理医学 临界护理医学
- 生物医学工程 生物医学工程
背景情况:
- 心脏性休克 (CS),通常来自急性心肌梗塞 (AMI),尽管有重血管化和机械循环支持 (MCS),但死亡率很高.
- 关于AMI-CS中短期皮肤穿MCS的当代证据正在不断发展,其中包括动脉内气球 (IABP),Impella和静脉脉外体膜氧化 (VA-ECMO) 的设备.
研究的目的:
- 审查当前关于AMI-CS.短期皮肤穿MCS的证据.
- 提供对设备选择和临床实施策略的见解.
主要方法:
- 随机对照试验的综合分析.
- 欧洲和北美社会提出的关键指导方针建议的审查.
主要成果:
- 动脉内气球 (IABP) 在AMI-CS.最近的试验中缺乏证明的死亡益处.
- 伊佩拉装置提供左心室卸载,具有潜在的生存益处,但更高的并发症.
- VA-ECMO提供全方位支持,但并发症率很高,可能需要辅助卸载;最近的试验显示没有明显的生存优势.
结论:
- 没有任何单一的MCS设备能够持续改善所有AMI-CS患者的存活率.
- 个性化,以表型驱动的策略,包括血液动力学分析是至关重要的.
- 需要进行进一步的研究,以优化CS中MCS的设备选择,时间和患者标准.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
337
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
337
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.0K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.0K
Acute Coronary Syndrome I: Introduction
1.2K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy
667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Cardiomyopathy V: Interprofessional Care
534
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534


